CREB3L1 and adrenal cortex carcinoma: Our results of Kaplan-Meier OS analysis demonstrated that among patients with ACC (p = 0.025) and UCEC (p = 0.004), longer survival time was presented in those who with high levels of CREB3L1 expression, however, in patients with KIRP (p = 0.024), MESO (p = 0.014), SKCM (p = 0.007), LGG (p = 0.020) and SARC (p = 0.045), high CREB3L1 expression levels were associated with poor OS (Figure 4A).